Revenue (Tables)

3 Months Ended

Mar. 31, 2020

Revenue [Abstract]

Disaggregation of Revenue [Table Text Block]

The following table presents the approximate percentage of our net sales by market group:

	Three Months Ended March 31,
	2020		2019
Biologics	28	%	26	%
Generics	19	%	20	%
Pharma	29	%	31	%
Contract-Manufactured Products	24	%	23	%
	100	%	100	%

The following table presents the approximate percentage of our net sales by product category:

	Three Months Ended March 31,
	2020		2019
High-Value Components	43	%	43	%
Standard Packaging	28	%	30	%
Delivery Devices	5	%	4	%
Contract-Manufactured Products	24	%	23	%
	100	%	100	%

The following table presents the approximate percentage of our net sales by geographic location:

	Three Months Ended March 31,
	2020		2019
Americas	48	%	46	%
Europe, Middle East, Africa	44	%	47	%
Asia Pacific	8	%	7	%
	100	%	100	%

Change in Contract with Customer, Asset and Liability [Abstract]

The following table summarizes our contract assets and liabilities, excluding contract assets included in accounts receivable, net:

	($ in millions)
Contract assets, December 31, 2019	$	9.8
Contract assets, March 31, 2020	16.4
Change in contract assets - increase (decrease)	$	6.6
Deferred income, December 31, 2019	$	(34.9)
Deferred income, March 31, 2020	(41.8)
Change in deferred income - decrease (increase)	$	(6.9)